RT Journal Article
SR Electronic
T1 Weighted 2D-kernel density estimations provide a new probabilistic measure for epigenetic age
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2024.06.10.598169
DO 10.1101/2024.06.10.598169
A1 Perez-Correa, Juan-Felipe
A1 Stiehl, Thomas
A1 Marioni, Riccardo E.
A1 Corley, Janie
A1 Cox, Simon R.
A1 Costa, Ivan G.
A1 Wagner, Wolfgang
YR 2024
UL http://biorxiv.org/content/early/2024/06/11/2024.06.10.598169.abstract
AB Background Epigenetic aging signatures can provide insights into the human aging process. Within the last decade many alternative epigenetic clocks have been described, which are typically based on linear regression analysis of DNA methylation at multiple CG dinucleotides (CpGs). However, this approach assumes that the epigenetic modifications follow either a continuous linear or logarithmic trajectory. In this study, we explored an alternative non-parametric approach using 2D-kernel density estimation (KDE) to determine epigenetic age.Results We used Illumina BeadChip profiles of blood samples of various studies, exemplarily selected the 27 CpGs with highest linear correlation with chronological age (R2 > 0.7), and computed KDEs for each of them. The probability profiles for individual KDEs were further integrated by a genetic algorithm to assign an optimal weight to each CpG. Our weighted 2D-kernel density estimation model (WKDE) facilitated age-predictions with similar correlation and precision (R2 = 0.81, median absolute error = 4 years) as other commonly used clocks. Furthermore, our approach provided a variation score, which reflects the inherent variation of age-related epigenetic changes at different CpG sites within a given sample. An increase of the variation score by one unit reduced the mortality risk by 9.2% (95% CI (0.8387, 0.9872), P <0.0160) in the Lothian Birth Cohort 1921 after adjusting for chronological age and sex.Conclusions We describe a new method using weighted 2D-kernel density estimation (WKDE) for accurate epigenetic age-predictions and to calculate variation scores, which provide an additional variable to estimate biological age.Competing Interest StatementW.W. is cofounder of Cygenia GmbH that can provide service for various other epigenetic signatures (www.cygenia.com). J-F.P-C. contributes to this company, too. Apart from this, the authors have no competing interests.